(Q34980270)

5 August 2017

1 reference

title

Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis (English)

1 reference

5 August 2017

Niladri Ganguly

1

1 reference

5 August 2017

Suraj P Parihar

series ordinal

2

1 reference

5 August 2017

publication date

1 March 2009

1 reference

5 August 2017

published in

Journal of Biosciences

1 reference

5 August 2017

volume

34

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

113-123

1 reference

Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

Regulation of apoptosis by the papillomavirus E6 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-009-0013-7

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

21 January 2018

1 reference

12 December 2020

The regulation of E2F by pRB-family proteins

1 reference

12 December 2020

Evolving views of telomerase and cancer

1 reference

12 December 2020

High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

1 reference

12 December 2020

Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.

1 reference

12 December 2020

Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro

1 reference

12 December 2020

PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6

1 reference

12 December 2020

Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation

1 reference

12 December 2020

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

1 reference

12 December 2020

Human papillomavirus immortalization and transformation functions

1 reference

12 December 2020

The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints.

1 reference

12 December 2020

Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein

1 reference

12 December 2020

Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins

1 reference

12 December 2020

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

1 reference

12 December 2020

Papillomavirus genome structure, expression, and post-transcriptional regulation

1 reference

12 December 2020

Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences

1 reference

12 December 2020

HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation

1 reference

12 December 2020

Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein

1 reference

12 December 2020

The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

1 reference

12 December 2020

E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc

1 reference

12 December 2020

Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells

1 reference

12 December 2020

p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells

1 reference

12 December 2020

Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor

1 reference

12 December 2020

The role of the human papilloma virus in esophageal cancer

1 reference

12 December 2020

Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein

1 reference

12 December 2020

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

1 reference

12 December 2020

Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

1 reference

12 December 2020

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3

1 reference

12 December 2020

Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame

1 reference

12 December 2020

Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites

1 reference

12 December 2020

HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells.

1 reference

12 December 2020

Differential localization of HPV16 E6 splice products with E6-associated protein

1 reference

12 December 2020

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

1 reference

12 December 2020

Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins

1 reference

12 December 2020

E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

1 reference

12 December 2020

Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome

1 reference

12 December 2020

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

12 December 2020

The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth

1 reference

12 December 2020

Human papillomavirus detected in female breast carcinomas in Japan

1 reference

12 December 2020

The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells

1 reference

12 December 2020

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

1 reference

12 December 2020

Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.

1 reference

12 December 2020

Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes

1 reference

12 December 2020

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

1 reference

12 December 2020

Clinical implications of human papillomavirus in head and neck cancers

1 reference

12 December 2020

Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

1 reference

12 December 2020

Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.

1 reference

12 December 2020

Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein

1 reference

12 December 2020

BRCA1 interaction with human papillomavirus oncoproteins

1 reference

12 December 2020

Human papillomavirus associated with oesophageal cancer.

1 reference

12 December 2020

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation

1 reference

12 December 2020

Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein

1 reference

12 December 2020

Regulation of Notch1 gene expression by p53 in epithelial cells

1 reference

12 December 2020

Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis

1 reference

12 December 2020

Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein

1 reference

12 December 2020

Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.

1 reference

12 December 2020

The role of human papillomavirus oncoproteins E6 and E7 in apoptosis

1 reference

12 December 2020

Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

1 reference

12 December 2020

Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner

1 reference

12 December 2020

E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein

1 reference

12 December 2020

Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation

1 reference

12 December 2020

The role of human papilloma virus in the molecular biology of cervical carcinogenesis.

1 reference

12 December 2020

Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600

1 reference

12 December 2020

Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53

1 reference

12 December 2020

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

1 reference

12 December 2020

Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

1 reference

12 December 2020

Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

1 reference

12 December 2020

PDZ domains - common players in the cell signaling

1 reference

12 December 2020

Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes

1 reference

12 December 2020

Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16

1 reference

12 December 2020

Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas.

1 reference

12 December 2020

Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex

1 reference

12 December 2020

Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers

1 reference

12 December 2020

Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity

1 reference

12 December 2020

The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.

1 reference

12 December 2020

Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells

1 reference

12 December 2020

Telomerase activation by the E6 gene product of human papillomavirus type 16.

1 reference

12 December 2020

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

1 reference

12 December 2020

Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation

1 reference

12 December 2020

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

1 reference

12 December 2020

Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells

1 reference

12 December 2020

Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance

1 reference

12 December 2020

The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.

1 reference

12 December 2020

Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins

1 reference

12 December 2020

The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo

1 reference

12 December 2020

Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes

1 reference

12 December 2020

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes

1 reference

12 December 2020

Mechanisms of human papillomavirus-induced oncogenesis.

1 reference

12 December 2020

HPV-mediated cervical carcinogenesis: concepts and clinical implications

1 reference

12 December 2020

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

12 December 2020

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

12 December 2020

The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.

1 reference

12 December 2020

HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation

1 reference

12 December 2020

Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates

1 reference

12 December 2020

Pathogenesis of human papillomaviruses in differentiating epithelia

1 reference

12 December 2020

Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins

1 reference

12 December 2020

HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background

1 reference

12 December 2020

Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis

1 reference

12 December 2020

Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins

1 reference

12 December 2020

Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin

1 reference

12 December 2020

p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China.

1 reference

12 December 2020

Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation

1 reference

12 December 2020

Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.

1 reference

12 December 2020

The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins

1 reference

12 December 2020

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

1 reference

12 December 2020

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

12 December 2020

The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

1 reference

12 December 2020

Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

1 reference

12 December 2020

Association of human papillomavirus type 11 with carcinoma of the penis.

1 reference

12 December 2020

Expression of HPV16 E6 or E7 increases integration of foreign DNA.

1 reference

12 December 2020

Identification of the alpha6 integrin as a candidate receptor for papillomaviruses

1 reference

12 December 2020

The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31.

1 reference

12 December 2020

Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer

1 reference

12 December 2020

Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro

1 reference

12 December 2020

The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities

1 reference

12 December 2020

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

12 December 2020

Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer

1 reference

12 December 2020

Human papillomavirus DNA in oesophageal carcinomas in South Africa

1 reference

12 December 2020

Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A

1 reference

12 December 2020

Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter

1 reference

12 December 2020

E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice

1 reference

12 December 2020

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

1 reference

12 December 2020

High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study

1 reference

12 December 2020

Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.

1 reference

12 December 2020

Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein

1 reference

12 December 2020

10.1007/S12038-009-0013-7

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1032426809

0 references

1 reference